Skip to main content

Table 1 Description of population. Anthropometric data, CVD-risk factors (given as n/% of population), routine laboratory data at baseline and average self reported training effort per month. Data is given as mean +/− standard deviation

From: Endurance training significantly increases serum endocan but not osteoprotegerin levels: a prospective observational study

n (f/m)

61 (19/42)

Risk factors

 Overweight

38/62,3

 Hypertension

19/31,1

 Dyslipidemia

17/27,9

 Hyperglycemia/DM

1/1,6

 Current Smoking

11/18

 Known CVD

13/21,3

 Pos. family history

26/42,6

Anthropometrics

 Age (years)

48,9 ± 6,9

 BMI (kg/m2)

27,5 ± 4,3

 Body water (%)

52,9 ± 5,9

 Body fat (%)

29,0 ± 10,4

 Body muscle (%)

35,6 ± 4,1

Laboratory analysis

 Erythrocytes (T/l)

4,8 ± 0,4

 Haemoglobin (g/dl)

14,2 ± 1,2

 Haematocrit (%)

40,6 ± 3,1

 Thrombocytes (G/l)

238,6 ± 48,5

 Leukocytes (G/l)

6,3 ± 1,3

 Na (mmol/l)

141,3 ± 1,6

 K (mmol/l)

4,2 ± 0,3

 Cl (mmol/l)

101,0 ± 2,0

 Ca (mmol/l)

2,3 ± 0,1

 Mg (mmol/l)

0,8 ± 0,1

 Creatinine (mg/dl)

0,9 ± 0,2

 Urea (mg/dl)

16,8 ± 17,9

 Uric acid (mg/dl)

5,2 ± 1,2

 Albumin (g/l)

45,0 ± 2,3

 Lipase (U/l)

40,4 ± 16,8

 Cholin esterasis (kU/l)

8,4 ± 1,7

 GOT (U/l)

23,9 ± 6,8

 GPT (U/l)

26,1 ± 12,0

 γ-GT (U/l)

32,4 ± 53,3

 Triglycerides (mg/dl)

133,6 ± 73,9

 Cholesterol (mg/dl)

201,2 ± 37,2

 HDL-cholesterol (mg/dl)

57,1 ± 15,2

 LDL-cholesterol (mg/dl)

118,1 ± 34,5

 HbA1c (rel.%)

5,2 ± 0,3

Average training effort (min./month)

 Moderate intensity

1211 ± 1003

 Vigorous intensity

332 ± 359

  1. GOT Glutamat-Oxalacetat-Transaminasis, GPT Glutamat-Pyruvat-Transaminasis, γ-GT γ-Glutamyltransferasis, HDL-cholesterol high density lipoprotein cholesterol, LDL-cholesterol low density lipoprotein cholesterol